Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retisert in Wet AMD
NCT00032396Phase 2Unknown
- Sponsor
- Control Delivery Systems
- Start
- Nov 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluocinolone in exudative macular degeneration, sponsored by Control Delivery Systems. Status: unknown.
02
Drugs
fluocinolone
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT00032396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032396.